首页 | 本学科首页   官方微博 | 高级检索  
     


Xp11.2 translocation renal cell carcinoma with SFPQ/PSF-TFE3 fusion gene: A case report with unusual histopathologic findings
Authors:Noriyoshi Ishikawa  Mamiko Nagase  Saki Takami  Nahoko Nagano  Asuka Araki  Teruaki Iwahashi  Naotaka Yamauchi  Taku Yamasaki  Hiroaki Shiina  Riruke Maruyama
Affiliation:1. Department of Surgical Pathology, Shimane University Hospital, 89-1 Enya, Izumo, Shimane 693-8501, Japan;2. Department of Organ Pathology, Shimane University School of Medicine, 89-1 Enya, Izumo, Shimane 693-8501, Japan;3. Department of Urology, Shimane University Hospital, 89-1 Enya, Izumo, Shimane 693-8501, Japan
Abstract:Xp11.2 translocation renal cell carcinoma (Xp11tRCC) is a subtype of renal cell carcinoma (RCC) characterized by chromosomal rearrangement of the region harboring the transcription factor for immunoglobulin heavy-chain enhancer 3 (TFE3). Xp11tRCCs comprises 20% to 40% of RCCs of children and adolescents and is generally associated with good prognosis. However in adult, the incidence of this tumor is relatively low (1% to 4%), suggesting a more aggressive course. TFE3 gene is fused by translocation to numerous partner genes, and definitive molecular characteristics can be difficult to verify. In this case report, we presented a case of Xp11tRCC with the SFPQ/PSF-TFE3 chimeric gene. The fusion gene was detected by 5'-rapid amplification of cDNA ends (5'RACE). The tumor was found to be in an advanced stage with multiple lymph node metastases. The histological characteristics of the tumor were different from those of XP11tRCC with other more frequently detected fusion genes.
Keywords:Corresponding author.  Xp11.2 translocation RCC  5’RACE  Solid variant
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号